The Cardiovascular System
From Bench to Bedside
- 1st Edition - July 31, 2025
- Imprint: Academic Press
- Editor: Hussein Hassan Sabit
- Language: English
- Paperback ISBN:9 7 8 - 0 - 4 4 3 - 2 9 8 9 0 - 5
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 2 9 8 9 1 - 2
The series "Stem Cell Innovation in Health & Disease" is a timely and fascinating collection of information and new discoveries and provides a contemporary snapshot album fro… Read more
Purchase options
The series "Stem Cell Innovation in Health & Disease" is a timely and fascinating collection of information and new discoveries and provides a contemporary snapshot album from the fast-moving field of regenerative medicine and stem cell therapeutics. The Cardiovascular System, Volume 6 addresses the recent data accumulated on the potential applications of stem cells to treat diseases and disorders of the cardiovascular system. This volume will highlight the recent developments of cutting-edge in vitro and in vivo research tools and approaches, including the human and murine organoid cultures, genetic editing in vitro and in vivo, human iPSC models of diseases, haploid cells for genetic as well as compound screening paradigms, genetically engineered mice, and stem cell transplantation to treat cardiovascular system disorders and diseases. The volume is written for researchers and scientists in stem cell therapy, cell biology, regenerative medicine, and organ transplantation; and is contributed by world-renowned authors in the field.
- Provides cutting-edge research to understand stem cell functions used in disease and disordertreatments of the cardiovascular system
- Develops processes to bring stem cells from bench to bedside
- Includes up to date references on stem cell biology and function in common cardiovascular system diseases and disorders
Stem cell biology scientists, regenerative medicine scientists, physicians and surgeons, Graduate and undergraduate students, researchers and practitioners in these fields
1. Organoid Culture System as Innovative Model of Heart Stem Cell-Based Cardiac Development and Diseases
Zulfugar Timur Taghiyev
2. Innovated Therapeutic Gene Editing Technologies in Stem Cell Engineering and Cardiovascular Disorders and Diseases
Emad Ali Al Khoufi
3. Cardiotoxivity and Cancer Therapy: Mechanisms, Implications, and Mitigation Strategies
Mariam Thabit
4. Advances in stem cell-based therapy of cardiovascular diseases and disorders
ahmed elbarbary
5. Derivation and Application of Embryonic Stem Cells as a Model for Heart Development Diseases and Disorders
Ahmed El-Hashash
6. The Potential of Mesenchymal Stem Cell Related Therapies for Cardiovascular Diseases and Disorders
Connor Case
7. Stem Cell Innovation in Cardiovascular Disease, Repair and Regeneration: General Conclusion, Challenges and Prospective
Ahmed El-Hashash
Zulfugar Timur Taghiyev
2. Innovated Therapeutic Gene Editing Technologies in Stem Cell Engineering and Cardiovascular Disorders and Diseases
Emad Ali Al Khoufi
3. Cardiotoxivity and Cancer Therapy: Mechanisms, Implications, and Mitigation Strategies
Mariam Thabit
4. Advances in stem cell-based therapy of cardiovascular diseases and disorders
ahmed elbarbary
5. Derivation and Application of Embryonic Stem Cells as a Model for Heart Development Diseases and Disorders
Ahmed El-Hashash
6. The Potential of Mesenchymal Stem Cell Related Therapies for Cardiovascular Diseases and Disorders
Connor Case
7. Stem Cell Innovation in Cardiovascular Disease, Repair and Regeneration: General Conclusion, Challenges and Prospective
Ahmed El-Hashash
- Edition: 1
- Published: July 31, 2025
- Imprint: Academic Press
- Language: English
HS
Hussein Hassan Sabit
Hussein Sabit graduated from Ain Shams University, Cairo and received his BSc in Genetics, where he also get his MSc in Microbial Genetics and PhD in Molecular Genetics. He joined Misr University for Science and Technology, Egypt as TA, Assistant Professor. Has been promoted to Associate Professor of Molecular Genetics, and Full Professor in Cancer Epigenetics. His research interest is Cancer Genetic/Epigenetic basis of carcinogenesis, genome editing via CRISPR/Cas9, studying the anti-apoptotic genes and its relations with BC progression, investigating the DNA methylation levels controlling carcinogenesis of BC, studying the chromatin remodelling as a main mechanisms leading to cancer using ChIP assays and others. He published 28 articles; most of them is the main field of Cancer Genetics/Epigenetics. He is the director of Cancer Epigenetics Research Unit (CERU) at MUST, where he leads a research team of postgrad students.
Affiliations and expertise
Misr University for Science and Technology, Egypt